Bowel Cancer Australia Becomes a Member of the Guidelines International Network

The Guidelines International Network (GIN) is delighted to welcome Bowel Cancer Australia, the leading Australian charity dedicated to championing what matters most to people impacted by bowel cancer and empowering those affected to live their best lives, as its newest organisational member.

Bowel Cancer Australia is currently in the early stages of developing age-specific clinical practice guidelines for early-onset bowel cancer. These guidelines will focus specifically on young Australians (those under the age of 50) who develop bowel cancer.

The project is funded by Bowel Cancer Australia and will be developed in collaboration with the Australian Living Evidence Collaboration (ALEC). ALEC partners with health professionals, people with lived experience, policymakers, and health organisations to develop and disseminate reliable, accessible, and up-to-date evidence that supports the best possible health decisions.

Julien Wiggins, Chief Executive Officer of Bowel Cancer Australia, said:

“Bowel Cancer Australia is pleased to become a member of the Guidelines International Network.

Each year, almost 1,900 Australians are diagnosed with early-onset bowel cancer (under age 50), and they are currently managed according to clinical practice guidelines that are not age-specific.

By becoming a member of a global community focused on producing high-quality, evidence-based guidelines, we look forward to working towards providing age-specific guidance for Australians diagnosed with early-onset bowel cancer.

International collaboration and robust guideline frameworks are essential if we are to improve diagnosis, management, and outcomes for young Australians.”

Daniela Carl, Chief Executive Officer of the Guidelines International Network, said:

“We are delighted to welcome Bowel Cancer Australia to the global Guidelines International Network.

As an international community dedicated to advancing high-quality, evidence-based guidelines, GIN is committed to supporting initiatives that strengthen guideline development and implementation. We are therefore very pleased to support this important project to develop rigorous clinical guidelines that will help improve health outcomes for people affected by early-onset bowel cancer.”